About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
PEER COMPARISON
Peer
Comparison
Abbott India Ltd.
Peer Companies
Price(Rs)
Chg(Rs)
Chg(%)
EPS(Rs.)
TTM P/E
Volume(000's)
1Year Return(%)
Divinded Yield
Book Value
Sanofi Cons. Health
5695.25
679.05
13.54
73.08
77.94
4913
0.97
118.26
Sanofi India
6375.85
187.7
3.03
156.83
40.65
990
-2.69
1.84
343.96
Divi's Lab
6811.45
153.5
2.31
83.21
81.86
3171
48.08
0.44
508.83
RPG Life Sciences
2480.45
76.35
3.18
110.79
22.39
1341
54.15
0.97
320.8
Wockhardt
1713.2
74.4
4.54
-0.74
0
63728
108
0
115.78
Alembic Pharma
1042.6
70.75
7.28
25.6
40.73
1244443
12.85
1.06
264.3
Torrent Pharma
3409.7
65.3
1.95
55.78
61.12
54636
22.68
0.94
201.76
Jenburkt Pharma
1372.1
64.75
4.95
72.64
18.89
2892
55.38
1.31
389.23
Ipca Laboratories
1388.3
54.5
4.09
25.65
54.12
6156
22.37
0
250.24
NGL Fine-Chem
1094.85
52.1
5
29.35
37.3
393
-52.87
0
425.39
Ajanta Pharma
2573.5
48.55
1.92
73.4
35.06
1917
14.11
1.09
289.84
Gland Pharma
1831.95
48.3
2.71
66.14
27.7
9902
0.67
0.98
546.04
Kwality Pharma
1060.4
45.85
4.52
38.44
27.58
26029
110.9
0
216.98
Natco Pharma
927.3
43.55
4.93
103.31
8.98
101875
-22.64
0.65
312.42
SMS Lifesciences
1219.3
42.8
3.64
70.68
17.25
36
43.19
0.12
582.9
Glenmark Pharma
1753.1
40.3
2.35
57.06
30.72
17802
38.51
0.14
813.92
Jubilant Pharmova
1209.2
35.5
3.02
1.21
0
12368
65.11
0.41
148.57
Kerala Ayurveda
598
34.9
6.2
-11.45
0
94857
93.68
0
32.62
Aarti Pharmalabs
892.15
32.9
3.83
28.39
31.42
17810
40.37
0.56
178.89
Caplin Point Lab
2116.75
32.15
1.54
44.66
47.39
7831
45.76
0.14
181.16
Page
1
of
10
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.